What is a stock summary page? Click here for an overview.
Business Description
China Medical System Holdings Ltd
ISIN : KYG211081248
Share Class Description:
FRA:2M7C: Ordinary SharesCompare
Compare
Traded in other countries / regions
00867.Hong Kong2M7C.GermanyCHSYF.USA IPO Date
2010-09-15Description
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil, Salofalk, Combizym, Ganfule Capsules, Xidakang, Hirudoid, and others.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 5.29 | |||||
| Equity-to-Asset | 0.88 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.64 | |||||
| Interest Coverage | 38.3 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 7.26 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.4 | |||||
| 3-Year EBITDA Growth Rate | -3.8 | |||||
| 3-Year EPS without NRI Growth Rate | -0.6 | |||||
| 3-Year FCF Growth Rate | -4.7 | |||||
| 3-Year Book Growth Rate | 9.4 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 7.14 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.2 | |||||
| 9-Day RSI | 42.97 | |||||
| 14-Day RSI | 47.35 | |||||
| 3-1 Month Momentum % | -1.62 | |||||
| 6-1 Month Momentum % | 13.04 | |||||
| 12-1 Month Momentum % | -35.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 4.28 | |||||
| Quick Ratio | 3.97 | |||||
| Cash Ratio | 2.95 | |||||
| Days Inventory | 127.24 | |||||
| Days Sales Outstanding | 63.13 | |||||
| Days Payable | 38.28 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 3.1 | |||||
| Dividend Payout Ratio | 0.7 | |||||
| 3-Year Dividend Growth Rate | 15.5 | |||||
| Forward Dividend Yield % | 3.1 | |||||
| 5-Year Yield-on-Cost % | 6.25 | |||||
| 3-Year Average Share Buyback Ratio | 0.3 | |||||
| Shareholder Yield % | 6.69 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 74.13 | |||||
| Operating Margin % | 25.51 | |||||
| Net Margin % | 19.78 | |||||
| FCF Margin % | 17.41 | |||||
| ROE % | 8.75 | |||||
| ROA % | 7.65 | |||||
| ROIC % | 12.58 | |||||
| 3-Year ROIIC % | -48.14 | |||||
| ROC (Joel Greenblatt) % | 108.57 | |||||
| ROCE % | 11.04 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.74 | |||||
| Forward PE Ratio | 8.43 | |||||
| PE Ratio without NRI | 12.74 | |||||
| Shiller PE Ratio | 7.78 | |||||
| Price-to-Owner-Earnings | 7.54 | |||||
| PEG Ratio | 1.68 | |||||
| PS Ratio | 2.52 | |||||
| PB Ratio | 1.11 | |||||
| Price-to-Tangible-Book | 1.71 | |||||
| Price-to-Free-Cash-Flow | 14.46 | |||||
| Price-to-Operating-Cash-Flow | 9.39 | |||||
| EV-to-EBIT | 7.88 | |||||
| EV-to-Forward-EBIT | 6.33 | |||||
| EV-to-EBITDA | 7.88 | |||||
| EV-to-Forward-EBITDA | 6.33 | |||||
| EV-to-Revenue | 1.99 | |||||
| EV-to-Forward-Revenue | 2.43 | |||||
| EV-to-FCF | 10.37 | |||||
| Price-to-GF-Value | 0.77 | |||||
| Price-to-Projected-FCF | 0.43 | |||||
| Price-to-DCF (Earnings Based) | 0.59 | |||||
| Price-to-DCF (FCF Based) | 0.47 | |||||
| Price-to-Median-PS-Value | 0.46 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.88 | |||||
| Price-to-Graham-Number | 1 | |||||
| Price-to-Net-Current-Asset-Value | 2.76 | |||||
| Price-to-Net-Cash | 4.7 | |||||
| Earnings Yield (Greenblatt) % | 12.68 | |||||
| FCF Yield % | 6.54 | |||||
| Forward Rate of Return (Yacktman) % | 21.14 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China Medical System Holdings Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 899.475 | ||
| EPS (TTM) (€) | 0.073 | ||
| Beta | 0.25 | ||
| 3-Year Sharpe Ratio | -0.14 | ||
| 3-Year Sortino Ratio | -0.19 | ||
| Volatility % | 55.06 | ||
| 14-Day RSI | 47.35 | ||
| 14-Day ATR (€) | 0.021328 | ||
| 20-Day SMA (€) | 0.95325 | ||
| 12-1 Month Momentum % | -35.92 | ||
| 52-Week Range (€) | 0.71 - 1.43 | ||
| Shares Outstanding (Mil) | 2,416.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
China Medical System Holdings Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
China Medical System Holdings Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| No Event Data | ||||
China Medical System Holdings Ltd Frequently Asked Questions
What is China Medical System Holdings Ltd(FRA:2M7C)'s stock price today?
The current price of FRA:2M7C is €0.94. The 52 week high of FRA:2M7C is €1.43 and 52 week low is €0.71.
When is next earnings date of China Medical System Holdings Ltd(FRA:2M7C)?
The next earnings date of China Medical System Holdings Ltd(FRA:2M7C) is .
Does China Medical System Holdings Ltd(FRA:2M7C) pay dividends? If so, how much?
The Dividend Yield %  of China Medical System Holdings Ltd(FRA:2M7C) is 3.1% (As of Today), Highest Dividend Payout Ratio of China Medical System Holdings Ltd(FRA:2M7C) was 0.7. The lowest was 0.28. And the median was 0.38. The  Forward Dividend Yield % of China Medical System Holdings Ltd(FRA:2M7C) is 3.1%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers